Sotera Health Past Earnings Performance
Past criteria checks 2/6
Sotera Health's earnings have been declining at an average annual rate of -31.6%, while the Life Sciences industry saw earnings growing at 16.4% annually. Revenues have been growing at an average rate of 7.4% per year. Sotera Health's return on equity is 11.6%, and it has net margins of 4.9%.
Key information
-31.6%
Earnings growth rate
-29.8%
EPS growth rate
| Life Sciences Industry Growth | 21.5% |
| Revenue growth rate | 7.4% |
| Return on equity | 11.6% |
| Net Margin | 4.9% |
| Next Earnings Update | 02 May 2024 |
Recent past performance updates
Recent updates
The Price Is Right For Sotera Health Company (NASDAQ:SHC) Even After Diving 29%
Mar 21
Sotera Health Company Just Missed Earnings - But Analysts Have Updated Their Models
Mar 01McIntyre Partnerships - Sotera Health Company: A Notable Outlier At A Discount
Feb 08Is Sotera Health (NASDAQ:SHC) A Risky Investment?
Feb 06Investors Still Aren't Entirely Convinced By Sotera Health Company's (NASDAQ:SHC) Revenues Despite 26% Price Jump
Dec 28Sotera Health Company's (NASDAQ:SHC) Intrinsic Value Is Potentially 33% Above Its Share Price
Dec 11An Intrinsic Calculation For Sotera Health Company (NASDAQ:SHC) Suggests It's 37% Undervalued
Sep 10Sotera Health Company (NASDAQ:SHC) Shares Could Be 24% Below Their Intrinsic Value Estimate
Jun 05Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 34%?
Feb 13Market Participants Recognise Sotera Health Company's (NASDAQ:SHC) Earnings Pushing Shares 29% Higher
Nov 24Sotera Health plunges 20% after jury awards $363M against its Sterigenics unit
Sep 19Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 49%?
Sep 08Sotera Health GAAP EPS of $0.11 misses by $0.05, revenue of $266.64M beats by $10.34M
Aug 04Is Sotera Health Company (NASDAQ:SHC) Trading At A 46% Discount?
May 09Returns On Capital Are Showing Encouraging Signs At Sotera Health (NASDAQ:SHC)
Mar 16Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 38%?
Jan 19A Look At The Fair Value Of Sotera Health Company (NASDAQ:SHC)
Sep 24Earnings Beat: Sotera Health Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 15Revenue & Expenses BreakdownBeta
How Sotera Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,049 | 51 | 160 | 0 |
| 30 Sep 23 | 991 | -306 | 180 | 0 |
| 30 Jun 23 | 976 | -268 | 169 | 0 |
| 31 Mar 23 | 988 | -261 | 171 | 0 |
| 31 Dec 22 | 1,004 | -234 | 166 | 0 |
| 30 Sep 22 | 993 | 121 | 163 | 0 |
| 30 Jun 22 | 971 | 123 | 158 | 0 |
| 31 Mar 22 | 956 | 135 | 152 | 0 |
| 31 Dec 21 | 931 | 115 | 149 | 0 |
| 30 Sep 21 | 907 | 36 | 152 | 0 |
| 30 Jun 21 | 881 | 9 | 150 | 0 |
| 31 Mar 21 | 842 | -26 | 140 | 0 |
| 31 Dec 20 | 818 | -39 | 137 | 0 |
| 30 Sep 20 | 795 | -23 | 119 | 0 |
| 30 Jun 20 | 790 | -28 | 128 | 0 |
| 31 Mar 20 | 772 | -29 | 132 | 0 |
| 31 Dec 19 | 778 | -21 | 132 | 0 |
| 31 Dec 18 | 746 | -6 | 126 | 0 |
Quality Earnings: SHC has a large one-off loss of $107.1M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: SHC became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SHC has become profitable over the past 5 years, growing earnings by -31.6% per year.
Accelerating Growth: SHC has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: SHC has become profitable in the last year, making it difficult to compare its past year earnings growth to the Life Sciences industry (-9.3%).
Return on Equity
High ROE: SHC's Return on Equity (11.6%) is considered low.